Literature DB >> 18514929

A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic.

Kevin M Goode1, Samantha Nabb, John G F Cleland, Andrew L Clark.   

Abstract

OBJECTIVE: The New York Heart Association (NYHA) classification is recommended for grading symptoms of chronic heart failure and is a powerful prognostic marker. Patient-rated NYHA (Pa-NYHA) and physician-rated NYHA (Dr-NYHA) class have never been compared directly, and it is unknown whether they carry similar prognostic significance. METHODS AND
RESULTS: NYHA class was rated independently by a physician and patient in 1752 patients referred with suspected heart failure. Pa-NYHA and Dr-NYHA varied by 1 class in 37.1% cases and by 2 classes in 12.8% cases. Mean Dr-NYHA and Pa-NYHA were higher in women than men (1.98 vs 1.89, P = .016; 2.17 vs 2.02, P = .002) despite less cardiac disease. Dr-NYHA correlated more with 6-minute walk test distance and severity of left ventricular systolic dysfunction than Pa-NYHA (Spearman's rho: -0.53 vs -0.44 and 0.32 vs 0.16). Dr-NYHA better predicted mortality when compared with Pa-NYHA (log-rank: chi(2) = 105 vs 46, both P < .001).
CONCLUSION: Patients rate NYHA differently from physicians, and women rate NYHA differently from men. Dr-NYHA relates more strongly to survival and severity of left ventricular systolic dysfunction, suggesting that for physicians the NYHA classification may have become a "heart failure severity score" and not as was intended, purely a measure of a patient's symptoms and functional status.

Entities:  

Mesh:

Year:  2008        PMID: 18514929     DOI: 10.1016/j.cardfail.2008.01.014

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  15 in total

Review 1.  [Percutaneous aortic valve replacement - pro].

Authors:  Lutz Buellesfeld; Eberhard Grube
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

Review 2.  Symptom burden in heart failure: assessment, impact on outcomes, and management.

Authors:  Craig M Alpert; Michael A Smith; Scott L Hummel; Ellen K Hummel
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

3.  Long-term assessment of nocturnal Cheyne-Stokes respiration in patients with heart failure.

Authors:  Offer Amir; Deganit Barak-Shinar; Rafael Wolff; Hagar Paz; Guy Dori; Frank W Smart; Basil S Lewis
Journal:  Sleep Breath       Date:  2010-12-02       Impact factor: 2.816

4.  Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction.

Authors:  Justin T Parizo; Jeremy D Goldhaber-Fiebert; Joshua A Salomon; Kiran K Khush; John A Spertus; Paul A Heidenreich; Alexander T Sandhu
Journal:  JAMA Cardiol       Date:  2021-08-01       Impact factor: 30.154

Review 5.  Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations.

Authors:  Alexandra Arvanitaki; Eleni Michou; Andreas Kalogeropoulos; Haralambos Karvounis; George Giannakoulas
Journal:  ESC Heart Fail       Date:  2020-05-05

Review 6.  The Limitations of Symptom-based Heart Failure Management.

Authors:  Lampros Papadimitriou; Charles K Moore; Javed Butler; Robert C Long
Journal:  Card Fail Rev       Date:  2019-05-24

7.  Assessing health-related quality of life in heart failure patients attending an outpatient clinic: a pragmatic approach.

Authors:  Angela M Gallagher; Rebecca Lucas; Martin R Cowie
Journal:  ESC Heart Fail       Date:  2018-10-11

8.  Beyond Type D personality: reduced positive affect (anhedonia) predicts impaired health status in chronic heart failure.

Authors:  Aline J Pelle; Susanne S Pedersen; Balázs M Szabó; Johan Denollet
Journal:  Qual Life Res       Date:  2009-05-09       Impact factor: 4.147

9.  Short-term vs. long-term heart rate variability in ischemic cardiomyopathy risk stratification.

Authors:  Andreas Voss; Rico Schroeder; Montserrat Vallverdú; Steffen Schulz; Iwona Cygankiewicz; Rafael Vázquez; Antoni Bayés de Luna; Pere Caminal
Journal:  Front Physiol       Date:  2013-12-13       Impact factor: 4.566

10.  Rationale and design of a risk-guided strategy for reducing readmissions for acute decompensated heart failure: the Risk-HF study.

Authors:  Georgios Zisis; Quan Huynh; Yang Yang; Christopher Neil; Melinda J Carrington; Jocasta Ball; Graeme Maguire; Thomas H Marwick
Journal:  ESC Heart Fail       Date:  2020-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.